sellModerate cluster of 3
Michael F. Huang sold $1.0M of SLNO
Sr. VP of Clinical Development at SOLENO THERAPEUTICS INC. 14,583 shares at an average of $69.51, traded Mar 27, 2025, filed Mar 31, 2025.
Warning score
50Value
$1.0M
14,583 shares
Holdings after
36,817
-35% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +25Trade size$1.0M at market
- +10Share of holdings soldSold 35% of holdings
- +15Cluster3 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-25-009294, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 27, 2025 | SOpen-market sale Common Stock | -371 | $65.97 | $24k | 41,029 | Mar 31, 2025 |
| Mar 27, 2025 | SOpen-market sale Common Stock | -604 | $66.79 | $40k | 40,425 | Mar 31, 2025 |
| Mar 27, 2025 | SOpen-market sale Common Stock | -1,098 | $67.70 | $74k | 39,327 | Mar 31, 2025 |
| Mar 27, 2025 | SOpen-market sale Common Stock | -1,444 | $68.79 | $99k | 37,883 | Mar 31, 2025 |
| Mar 27, 2025 | SOpen-market sale Common Stock | -836 | $69.84 | $58k | 37,047 | Mar 31, 2025 |
| Mar 27, 2025 | SOpen-market sale Common Stock | -86 | $70.73 | $6,083 | 36,961 | Mar 31, 2025 |
| Mar 27, 2025 | SOpen-market sale Common Stock | -125 | $71.74 | $8,968 | 36,836 | Mar 31, 2025 |
| Mar 27, 2025 | SOpen-market sale Common Stock | -19 | $72.64 | $1,380 | 36,817 | Mar 31, 2025 |
| Mar 27, 2025 | MOption exercise Common Stock | +10,000 | $21.93 | $219k | 46,817 | Mar 31, 2025 |
| Mar 27, 2025 | SOpen-market sale Common Stock | -10,000 | $70.03 | $700k | 36,817 | Mar 31, 2025 |
| Mar 27, 2025 | MOption exercise Employee stock option (right to buy)derivative | -10,000 | $0.00 | $0 | 110,000 | Mar 31, 2025 |
Related signals
Other insiders at SOLENO THERAPEUTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 32Weak | SLNOsell SOLENO THERAPEUTICS INC | Michael F. Huang Sr. VP of Clinical Development | $200k 6,582 shares | -14% | |
| 14Weak | SOLENO THERAPEUTICS INC | Patricia C Hirano SEE REMARKS | $317k 3,830 shares | -22% | |
| 0Weak | SOLENO THERAPEUTICS INC | Patricia C Hirano SEE REMARKS | $22k 266 shares | -2% | |
| 28Weak | SOLENO THERAPEUTICS INC | Patricia C Hirano SEE REMARKS | $265k 3,782 shares | -12% | |
| 70Notable | SOLENO THERAPEUTICS INC | Bhatnagar Anish CHIEF EXECUTIVE OFFICER | $47M 699,095 shares | -93% | |
| 40Moderate | SOLENO THERAPEUTICS INC | Patricia C Hirano SEE REMARKS | $11M 156,315 shares | -139% | |
| 58Moderate | SOLENO THERAPEUTICS INC | Bhatnagar Anish CHIEF EXECUTIVE OFFICER | $966k 21,091 shares | -3% | |
| 34Weak | SOLENO THERAPEUTICS INC | Patricia C Hirano SEE REMARKS | $139k 3,030 shares | -3% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.